Error: Could not add to watchlist. X
+ Watchlist

ImmunoGen Inc

IMGN:US
NASDAQ GS
2.43
USD
0.05
2.02%
As of 8:10 PM EST 1/20/2017
Open
2.48
Day Range
2.37 - 2.48
Volume
1,295,291
Previous Close
2.48
52Wk Range
1.51 - 10.22
1 Yr Return
-75.20%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Open
2.48
Day Range
2.37 - 2.48
Volume
1,295,291
Previous Close
2.48
52Wk Range
1.51 - 10.22
1 Yr Return
-75.20%
YTD Return
19.12%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-1.76
Market Cap (m USD)
212.142
Shares Outstanding (m)
87.301
Price/Sales (TTM)
4.00
Dividend Indicated Gross Yield
-
Sector
Health Care
% Price Change
-0.29%
% Price Change
+1.47%

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
ImmunoGen, Inc. develops targeted anticancer therapeutics using its Targeted Antibody Payload (TAP) technology together with its expertise in monoclonal antibodies and tumor biology. The Company offers a TAP compound that uses a tumor-targeting monoclonal antibody to deliver one of ImmunoGen's purpose-developed cancer-killing agents specifically to tumor cells.
Address
830 Winter Street
Waltham, MA 02451-1477
United States
Phone
1-781-895-0600
Show More